Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 428 | 710 | 1,301 | 3,494 | 4,251 |
| Marketable Securities | 15,527 | 16,441 | 18,394 | 17,855 | 4,290 |
| Receivables | 759 | 823 | 252 | 693 | 1,005 |
| TOTAL | $16,788 | $18,091 | $20,061 | $22,078 | $9,578 |
| Non-Current Assets | |||||
| PPE Net | 271 | 268 | 282 | 290 | 313 |
| Other Non-Current Assets | 21 | 0 | 20 | 19 | 20 |
| TOTAL | $292 | $268 | $302 | $309 | $333 |
| Total Assets | $17,080 | $18,359 | $20,363 | $22,387 | $9,911 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,452 | 530 | 1,021 | 1,155 | 1,766 |
| Accrued Expenses | 1,500 | 2,308 | 1,505 | 1,571 | 1,347 |
| TOTAL | $2,952 | $2,838 | $2,526 | $2,726 | $3,113 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 123 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $123 |
| Total Liabilities | $2,952 | $2,838 | $2,526 | $2,726 | $3,236 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,244 | 1,234 | 1,233 | 1,233 | 1,227 |
| Common Shares | 11 | 13 | 13 | 13 | 11 |
| Retained earnings | -70,141 | -68,757 | -66,154 | -63,889 | -61,653 |
| TOTAL | $14,128 | $15,521 | $17,837 | $19,661 | $6,675 |
| Total Liabilities And Equity | $17,080 | $18,359 | $20,363 | $22,387 | $9,911 |